Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 17 studies | 30% ± 11% | |
macrophage | 13 studies | 33% ± 14% | |
ciliated cell | 11 studies | 27% ± 6% | |
oligodendrocyte | 11 studies | 36% ± 13% | |
astrocyte | 11 studies | 33% ± 15% | |
B cell | 11 studies | 24% ± 8% | |
microglial cell | 10 studies | 33% ± 13% | |
fibroblast | 10 studies | 25% ± 7% | |
oligodendrocyte precursor cell | 9 studies | 32% ± 15% | |
adipocyte | 9 studies | 31% ± 7% | |
GABAergic neuron | 8 studies | 40% ± 21% | |
non-classical monocyte | 8 studies | 23% ± 7% | |
glutamatergic neuron | 8 studies | 43% ± 25% | |
epithelial cell | 8 studies | 31% ± 15% | |
classical monocyte | 7 studies | 22% ± 6% | |
myeloid cell | 7 studies | 30% ± 10% | |
monocyte | 7 studies | 32% ± 15% | |
neuron | 6 studies | 35% ± 19% | |
dendritic cell | 6 studies | 30% ± 4% | |
T cell | 6 studies | 24% ± 5% | |
endothelial cell of lymphatic vessel | 6 studies | 24% ± 6% | |
smooth muscle cell | 6 studies | 20% ± 3% | |
interneuron | 5 studies | 44% ± 22% | |
CD8-positive, alpha-beta T cell | 5 studies | 19% ± 5% | |
cardiac muscle cell | 5 studies | 29% ± 6% | |
mast cell | 5 studies | 23% ± 6% | |
basal cell | 5 studies | 30% ± 14% | |
natural killer cell | 5 studies | 24% ± 5% | |
goblet cell | 5 studies | 28% ± 17% | |
club cell | 5 studies | 24% ± 7% | |
pericyte | 5 studies | 23% ± 6% | |
type I pneumocyte | 5 studies | 28% ± 6% | |
type II pneumocyte | 5 studies | 25% ± 6% | |
lymphocyte | 4 studies | 32% ± 11% | |
respiratory goblet cell | 4 studies | 29% ± 10% | |
CD16-negative, CD56-bright natural killer cell, human | 3 studies | 22% ± 6% | |
hematopoietic precursor cell | 3 studies | 20% ± 3% | |
glial cell | 3 studies | 18% ± 3% | |
granule cell | 3 studies | 21% ± 4% | |
plasma cell | 3 studies | 23% ± 5% | |
CD4-positive, alpha-beta T cell | 3 studies | 21% ± 5% | |
mesothelial cell | 3 studies | 28% ± 7% | |
mononuclear phagocyte | 3 studies | 25% ± 7% | |
glycinergic amacrine cell | 3 studies | 17% ± 2% | |
endothelial cell of vascular tree | 3 studies | 28% ± 10% | |
hepatocyte | 3 studies | 41% ± 21% | |
abnormal cell | 3 studies | 27% ± 12% | |
alveolar macrophage | 3 studies | 47% ± 10% | |
naive B cell | 3 studies | 17% ± 1% | |
leukocyte | 3 studies | 38% ± 11% | |
transit amplifying cell | 3 studies | 34% ± 25% | |
mucus secreting cell | 3 studies | 27% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3417.39 | 1445 / 1445 | 100% | 25.11 | 183 / 183 |
stomach | 100% | 3401.01 | 359 / 359 | 99% | 18.67 | 284 / 286 |
intestine | 100% | 4325.39 | 966 / 966 | 99% | 18.05 | 522 / 527 |
lung | 100% | 4683.97 | 578 / 578 | 99% | 18.60 | 1142 / 1155 |
thymus | 100% | 5858.87 | 653 / 653 | 98% | 28.13 | 595 / 605 |
pancreas | 100% | 2618.62 | 328 / 328 | 98% | 19.35 | 175 / 178 |
prostate | 100% | 4175.81 | 245 / 245 | 98% | 26.75 | 493 / 502 |
breast | 100% | 4173.51 | 459 / 459 | 98% | 28.10 | 1097 / 1118 |
bladder | 100% | 4326.38 | 21 / 21 | 98% | 15.63 | 494 / 504 |
brain | 99% | 2066.00 | 2603 / 2642 | 99% | 19.43 | 700 / 705 |
kidney | 100% | 3168.51 | 89 / 89 | 97% | 20.03 | 876 / 901 |
skin | 100% | 4730.99 | 1809 / 1809 | 96% | 18.11 | 452 / 472 |
uterus | 100% | 3744.13 | 170 / 170 | 96% | 14.79 | 439 / 459 |
ovary | 100% | 3801.77 | 180 / 180 | 93% | 11.73 | 402 / 430 |
adrenal gland | 100% | 4400.71 | 258 / 258 | 90% | 10.95 | 207 / 230 |
liver | 100% | 2108.59 | 226 / 226 | 87% | 10.29 | 353 / 406 |
adipose | 100% | 3918.63 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3261.08 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 2673.93 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 6398.80 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.37 | 1 / 1 |
peripheral blood | 99% | 4705.98 | 921 / 929 | 0% | 0 | 0 / 0 |
heart | 97% | 2593.24 | 831 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 16.44 | 43 / 45 |
eye | 0% | 0 | 0 / 0 | 90% | 11.38 | 72 / 80 |
lymph node | 0% | 0 | 0 / 0 | 86% | 14.63 | 25 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007040 | Biological process | lysosome organization |
GO_0061744 | Biological process | motor behavior |
GO_0048741 | Biological process | skeletal muscle fiber development |
GO_0007528 | Biological process | neuromuscular junction development |
GO_0007409 | Biological process | axonogenesis |
GO_1905037 | Biological process | autophagosome organization |
GO_0008088 | Biological process | axo-dendritic transport |
GO_0051668 | Biological process | localization within membrane |
GO_0007268 | Biological process | chemical synaptic transmission |
GO_0006606 | Biological process | protein import into nucleus |
GO_0048675 | Biological process | axon extension |
GO_0007613 | Biological process | memory |
GO_0097049 | Biological process | motor neuron apoptotic process |
GO_0090389 | Biological process | phagosome-lysosome fusion involved in apoptotic cell clearance |
GO_0033344 | Biological process | cholesterol efflux |
GO_2001256 | Biological process | regulation of store-operated calcium entry |
GO_0021957 | Biological process | corticospinal tract morphogenesis |
GO_0090659 | Biological process | walking behavior |
GO_0048489 | Biological process | synaptic vesicle transport |
GO_0005730 | Cellular component | nucleolus |
GO_0005886 | Cellular component | plasma membrane |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0030425 | Cellular component | dendrite |
GO_0005829 | Cellular component | cytosol |
GO_0045202 | Cellular component | synapse |
GO_0005737 | Cellular component | cytoplasm |
GO_0030424 | Cellular component | axon |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0019901 | Molecular function | protein kinase binding |
GO_0005515 | Molecular function | protein binding |
Gene name | SPG11 |
Protein name | SPG11 vesicle trafficking associated, spatacsin Spatacsin KIAA1840, isoform CRA_a (SPG11 vesicle trafficking associated, spatacsin) Spatacsin (Colorectal carcinoma-associated protein) (Spastic paraplegia 11 protein) |
Synonyms | hCG_2004168 KIAA1840 |
Description | FUNCTION: May play a role in neurite plasticity by maintaining cytoskeleton stability and regulating synaptic vesicle transport. . |
Accessions | A0A075B718 ENST00000682460.1 ENST00000261866.12 [Q96JI7-1] ENST00000682065.1 ENST00000558138.2 ENST00000683573.1 ENST00000557866.1 H0YLR8 ENST00000535302.6 [Q96JI7-3] Q96JI7 ENST00000683255.1 ENST00000682669.1 A0A804HKV6 ENST00000684676.1 ENST00000684038.1 ENST00000683186.1 A0A804HI84 A0A804HI99 ENST00000427534.6 ENST00000559511.6 A0A804HID9 ENST00000683496.1 ENST00000558319.5 [Q96JI7-2] A0A804HJG2 A0A804HK59 A0A804HKQ8 ENST00000682788.1 ENST00000682495.1 ENST00000683734.1 C4B7M3 ENST00000683121.1 ENST00000559193.5 A0A804HLG4 C4B7M4 ENST00000682915.1 A0A804HIM5 A0A804HLE6 H0YLK7 A0A804HLC5 ENST00000684235.1 C4B7M2 H0YN34 A0A804HLF9 A0A804HJL9 A0A804HIP5 |